Molndal, Sweden

Maria Saxin

This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maria Saxin. Retrieved from https://idiyas.com/inventor/maria-saxin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Maria Saxin: Innovator in Gastrointestinal Treatments

Introduction

Maria Saxin is a prominent inventor based in Molndal, Sweden. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of gastrointestinal disorders. Her innovative work has led to the development of novel compounds that have the potential to improve patient outcomes.

Latest Patents

Maria Saxin holds 1 patent for her invention titled "Imidazole derivatives for the treatment of gastrointestinal disorders." This patent describes novel imidazole derivatives that exhibit a positive allosteric GABAB receptor modulator effect. The invention outlines methods for preparing these compounds and their use in combination with a GABAB agonist to inhibit transient lower esophageal sphincter relaxations. This approach is aimed at treating gastroesophageal reflux disease, functional gastrointestinal disorders, and irritable bowel syndrome (IBS). The compounds are represented by a general formula where specific substituents are defined in the description.

Career Highlights

Maria Saxin is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. Her work at AstraZeneca has allowed her to focus on innovative solutions for gastrointestinal health. She has been instrumental in advancing research that bridges the gap between basic science and clinical application.

Collaborations

Maria has collaborated with notable colleagues, including Udo Bauer and Wayne Brailsford. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic options.

Conclusion

Maria Saxin's contributions to the field of gastrointestinal treatments exemplify her dedication to innovation and patient care. Her patented work on imidazole derivatives showcases her ability to address complex medical challenges. Through her career at AstraZeneca and collaborations with esteemed colleagues, she continues to make a significant impact in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…